| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $12.39B | +2.6% |
| Cost of Revenue | $7.88B | +0.6% |
| R&D Expense | $531.0M | +4.5% |
| SG&A Expense | $1.55B | +10.2% |
| Interest Expense | $366.0M | -7.6% |
| Pre-tax Income | $1.19B | +136.5% |
| Income Tax | $414.0M | +1527.6% |
| Net Income | $703.0M | +66.2% |
| EPS (Basic) | $1.68 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.85B | -22.7% |
| Accounts Receivable | $1.53B | +1.4% |
| Inventory | $2.13B | -0.8% |
| Current Assets | $6.36B | -15.3% |
| Total Assets | $36.64B | -5.0% |
| Current Liabilities | $4.80B | +55.0% |
| Long-term Debt | $5.32B | -32.3% |
| +78.7% |
| EPS (Diluted) | $1.67 | +77.7% |
| Total Liabilities |
| $12.84B |
| -7.1% |
| Stockholders' Equity | $23.35B | -3.8% |